Fluocinonide Gel Recalled for Manufacturing Process Deviations
Teligent Pharma, Inc. is recalling all Fluocinonide Gel USP 0.05% nationwide within expiration date due to manufacturing deviations related to discontinued stability studies.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II precautionary recall due to cGMP deviations and the firm's discontinuation of stability studies. No illnesses or injuries have been reported. Per the rubric, voluntary precautionary recalls are scored as Moderate.
Plain-English summary
Teligent Pharma, Inc. is recalling all Fluocinonide Gel USP, 0.05%, that remain within their expiration dates. The product is packaged in 15 g, 30 g, and 60 g tubes under three NDC numbers. The recall is due to current Good Manufacturing Practice (cGMP) deviations: the manufacturing firm is discontinuing its stability study program for this product.
The affected product was distributed nationwide in the USA and Puerto Rico. A total of 51,748 tubes are subject to this recall.
Consumers who have this product should discontinue use and consult their healthcare provider regarding alternative treatment options. Affected patients should follow Teligent Pharma's instructions for product return and disposal.
The recalled product
- Product
- Fluocinonide Gel USP, 0.05%, packaged in a) 15 g tubes, NDC 52565-054-15; b) 60 g tubes, NDC 52565-054-60; c) 30 g tubes, NDC 52565-054-30, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Corticosteroid
- Hazard
- stability-issue
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Batch: a) 15122
- Exp. 2/28/2022
- 15475
- Exp. 3/31/2022
- b) 15119
- 15122
- 15380
- c) 15380
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27